2016 IATT Paediatric ARV Optimal Formulary List

Developed by the IATT in response to procurement and supply challenges resulting from fragmented demand for paediatric ARVs, and has been developing guidance around the selection of optimal products since 2011, this brief is intended for use by programme managers and policy makers and provides formulary selection and procurement guidance for the optimal paediatric ARV dosage forms needed to provide all WHO recommended 1st and 2nd line regimens while simplifying supply chain and easing administration. The brief includes both the Optimal Paediatric ARV formulary as well as the Limited Use list of those formulations that may be needed in special circumstances. As the Optimal Formulary and Limited Use lists are updated on a regular basis, explanation is provided for updates made since 2013.

IATT Paediatric ARV Formulary and Limited-Use List.pdf

Early testing and treatment and retention in care is the difference between life and death, especially for pregnant women and their babies. In Lesotho, where one in four people are living with HIV, services have become easier to access. Ntsejoa, 23, tells her story of how simplified and integrated services made a difference for her and her baby.

 

Integrating services to simplify care in Lesotho

We took text from our documents and asked what it really means. Turns out, it's simpler than we thought. "Think like a wise person, but communicate in the words of the people," William Butler Yates.

 

Communicating should be simple, right?

The Community Health Worker pilot project began in Bouake in 2014 in order to make a difference in health care practices at a grassroots level and encourage more women to go to health centres, and keep their follow-up appointments.

Community outreach informs decision making

Subscribe to 2016